Efficacy Of Loralatinib After Combination With Alectinib Central Lung Disease In One Patient In Kinase-Positive Anaplastic Lymphoma Small Cell Lung Cancer: A Case Report. Clinical and Medical Case Reports [Internet]. 2022 Jan. 27 [cited 2025 Jan. 23];2(01):31-4. Available from: https://currentopinion.info/index.php/cmcr/article/view/76